Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy by Lin‐Zhu Zhang, Xu He, Hai‐Dong Zhu

Get full text

Transarterial chemoembolization for hepatocellular carcinoma: Treatment algorithm proposed by Chinese College of Interventionalists (CCI) by Hai-Dong Zhu, Rong Liu, Zhong-Zhi Jia, Dong-Dong Xia, Bin-Yan Zhong, Wen-Zhe Fan, Jian Lu, Ming Zhao, Gao-Jun Teng

Get full text

Development of TACE Refractoriness Scores in Hepatocellular Carcinoma by Li Chen, Chen-Xi Yu, Bin-Yan Zhong, Hai-Dong Zhu, Zhi-Cheng Jin, Guang-Yu Zhu, Qi Zhang, Cai-Fang Ni, Gao-Jun Teng

Get full text

Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma by Zhi-Cheng Jin, Li Chen, Bin-Yan Zhong, Hai-Dong Zhu, Chu-Hui Zeng, Rui Li, Jin-He Guo, Shi-Cheng He, Gang Deng, Xiao-Li Zhu, Cai-Fang Ni, Gao-Jun Teng

Get full text

Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic Cancer by Hai-Feng Zhou, Yu-Qi Han, Yu-Qi Han, Jian Lu, Jing-Wei Wei, Jing-Wei Wei, Jin-He Guo, Hai-Dong Zhu, Ming Huang, Jian-Song Ji, Wei-Fu Lv, Li Chen, Guang-Yu Zhu, Zhi-Cheng Jin, Jie Tian, Jie Tian, Jie Tian, Jie Tian, Gao-Jun Teng

Get full text

Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213) by Zhi‐Cheng Jin, Jia‐Wei Zhou, Jian‐Jian Chen, Rong Ding, Bernhard Scheiner, Si‐Na Wang, Hai‐Liang Li, Qing‐Xia Shen, Qing‐Yun Lu, Yi Liu, Wei‐Hua Zhang, Biao Luo, Hai‐Bin Shi, Ming Huang, Ye‐Ming Wu, Chun‐Wang Yuan, Ming‐Sheng Huang, Jia‐Ping Li, Jian‐Bing Wu, Xiao‐Li Zhu, Bin‐Yan Zhong, Hai‐Feng Zhou, Yu‐Qing Wang, Shan‐Zhi Gu, Zhi‐Yi Peng, Chuan‐Sheng Zheng, Rui‐Bao Liu, Guo‐Hui Xu, Wei‐Zhu Yang, Ai‐Bing Xu, Dong‐Fang Liu, Xiaolong Qi, Yee Hui Yeo, Hai‐Dong Zhu, Yang Zhao, David J. Pinato, Fanpu Ji, Gao‐Jun Teng

Get full text

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001) by Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, Wei-Zhu Yang, Guo-Wen Yin, Bin-Yan Zhong, Jun-Hui Sun, Zhi-Cheng Jin, Jian-Jian Chen, Nai-Jian Ge, Wen-Bin Ding, Wen-Hui Li, Jin-Hua Huang, Wei Mu, Shan-Zhi Gu, Jia-Ping Li, Hui Zhao, Shu-Wei Wen, Yan-Ming Lei, Yu-Sheng Song, Chun-Wang Yuan, Wei-Dong Wang, Ming Huang, Wei Zhao, Jian-Bing Wu, Song Wang, Xu Zhu, Jian-Jun Han, Wei-Xin Ren, Zai-Ming Lu, Wen-Ge Xing, Yong Fan, Hai-Lan Lin, Zi-Shu Zhang, Guo-Hui Xu, Wen-Hao Hu, Qiang Tu, Hong-Ying Su, Chuan-Sheng Zheng, Yong Chen, Xu-Ya Zhao, Zhu-Ting Fang, Qi Wang, Jin-Wei Zhao, Ai-Bing Xu, Jian Xu, Qing-Hua Wu, Huan-Zhang Niu, Jian Wang, Feng Dai, Dui-Ping Feng, Qing-Dong Li, Rong-Shu Shi, Jia-Rui Li, Guang Yang, Hai-Bin Shi, Jian-Song Ji, Yu-E Liu, Zheng Cai, Po Yang, Yang Zhao, Xiao-Li Zhu, Li-Gong Lu, Gao-Jun Teng, for the CHANCE001 Investigators

Get full text